Relative risk for events according to day-7 bone marrow status and intensification regimen
| Day-7 bone marrow status . | 5-year EFS by randomized regimen % (SD) . | RR (DI vs DDI) . | ||
|---|---|---|---|---|
| DI (N = 405) . | DIVPI (N = 397) . | DDI (N = 402) . | ||
| M1 (less than 5% blasts) | 84 (3) | 82 (3) | 86 (3) | 1.16 |
| M2 (5%-25% blasts) | 77 (4) | 74 (5) | 89 (4) | 1.61 |
| M3 (more than 25% blasts) | 63 (6) | 77 (5) | 74 (5) | 1.64 |
| RR | ||||
| M2 vs M1 | 1.43 | 1.75 | 1.00 | |
| M3 vs M1 | 2.61 | 1.57 | 1.81 | |
| Log-rankP | .0008 | .07 | .07 | |
| Day-7 bone marrow status . | 5-year EFS by randomized regimen % (SD) . | RR (DI vs DDI) . | ||
|---|---|---|---|---|
| DI (N = 405) . | DIVPI (N = 397) . | DDI (N = 402) . | ||
| M1 (less than 5% blasts) | 84 (3) | 82 (3) | 86 (3) | 1.16 |
| M2 (5%-25% blasts) | 77 (4) | 74 (5) | 89 (4) | 1.61 |
| M3 (more than 25% blasts) | 63 (6) | 77 (5) | 74 (5) | 1.64 |
| RR | ||||
| M2 vs M1 | 1.43 | 1.75 | 1.00 | |
| M3 vs M1 | 2.61 | 1.57 | 1.81 | |
| Log-rankP | .0008 | .07 | .07 | |
EFS indicates event-free survival; RR, relative risk. See Table 1footnote for other abbreviations.